Income Statement Hosken Consolidated Investments Limited OTC Markets

Stocks

HKCIF

ZAE000003257

Consumer Goods Conglomerates

Market Closed - OTC Markets 12:45:39 2023-03-27 EDT			5-day change	1st Jan Change
0.3187 ^USD	+170.08%		-.--%	-

05-26	Hosken Consolidated Investments Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
05-26	Hosken Consolidated Investments Limited Declares Final Ordinary Dividend for the Year Ended 31 March 2026, Payable on 22 June 2026	CI

19d5860f0445ee.7aL4jrCh28Z7YyUYPBYA-kPfQEGpUULxU5Rkwo5hRsw.nfKg1OXTq48aDxRKX35pvDeyOXbxJQ-ACdoUgb0-PLjblLP-1fOssA8lRg

Published financial data: HOSKEN CONSOLIDATED INVESTMENTS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	19.13B	22.9B	23.73B	23.44B	24.17B
Total Revenues	19.13B	22.9B	23.73B	23.44B	24.17B
Cost of Goods Sold, Total	-	17.26B	17.69B	18.2B	18.74B
Gross Profit	19.13B	5.64B	6.05B	5.24B	5.43B
Depreciation & Amortization - (IS)	1.17B	1.16B	1.22B	1.13B	1.14B
Other Operating Expenses	14.11B	-	-	-	-
Other Operating Expenses, Total	15.28B	1.16B	1.22B	1.13B	1.14B
Operating Income	3.85B	4.48B	4.83B	4.11B	4.29B
Interest Expense, Total	-1.32B	-1.19B	-1.43B	-1.4B	-1.19B
Interest And Investment Income	149M	300M	259M	288M	246M
Net Interest Expenses	-1.17B	-895M	-1.17B	-1.11B	-942M
Income (Loss) On Equity Invest.	-93.6M	198M	-172M	77.44M	524M
Other Non Operating Income (Expenses)	9.4M	-70.84M	-59.81M	-25.01M	-15M
EBT, Excl. Unusual Items	2.6B	3.71B	3.43B	3.05B	3.85B
Impairment of Goodwill	-4.25M	-	-	-	-
Gain (Loss) On Sale Of Investments	181M	152M	477M	6.04B	756M
Asset Writedown	1.15B	2.85B	-2.77B	-1.53B	-70.11M
Other Unusual Items	-	-	-	-	2.38M
EBT, Incl. Unusual Items	3.93B	6.71B	1.13B	7.56B	4.54B
Income Tax Expense	713M	1.62B	388M	537M	1.05B
Earnings From Continuing Operations	3.21B	5.09B	746M	7.02B	3.49B
Earnings Of Discontinued Operations	-9.48M	-9.06M	-	-	-
Net Income to Company	3.2B	5.08B	746M	7.02B	3.49B
Minority Interest	-1.12B	-1.87B	-93.79M	-298M	-949M
Net Income - (IS)	2.08B	3.21B	652M	6.72B	2.54B
Net Income to Common Incl Extra Items	2.08B	3.21B	652M	6.72B	2.54B
Net Income to Common Excl. Extra Items	2.09B	3.22B	652M	6.72B	2.54B
Per Share Items
Net EPS - Basic	25.7	39.66	8.06	83.14	32.13
Basic EPS - Continuing Operations	25.82	39.77	8.06	83.14	32.13
Basic Weighted Average Shares Outstanding	80.87M	80.87M	80.87M	80.88M	79.02M
Net EPS - Diluted	25.68	38.94	7.89	81.72	31.95
Diluted EPS - Continuing Operations	25.8	39.05	7.89	81.72	31.95
Diluted Weighted Average Shares Outstanding	80.94M	82.3M	82.59M	82.28M	79.44M
Normalized Basic EPS	6.17	5.52	25.35	19.89	18.47
Normalized Diluted EPS	6.17	5.43	24.82	19.55	18.37
Dividend Per Share	-	0.5	1	1.7	2
Payout Ratio	-	15.55	107.34	19.94	21.62
Supplemental Items
EBITDA	5.03B	5.64B	6.05B	5.16B	5.35B
EBITA	3.87B	4.48B	4.83B	4.14B	4.32B
EBIT	3.85B	4.48B	4.83B	4.11B	4.29B
EBITDAR	5.17B	-	-	5.32B	5.48B
Total Revenues (As Reported)	19.13B	22.9B	23.73B	23.44B	24.17B
Effective Tax Rate - (Ratio)	18.17	24.15	34.24	7.11	23.2
Current Domestic Taxes	-	-	-	-	-
Current Foreign Taxes	-	-	-	-	42.87M
Total Current Taxes	641M	-	-	907M	972M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	74.45M	-	-	-376M	38.86M
Normalized Net Income	499M	447M	2.05B	1.61B	1.46B
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	44M	-	-	-	120K
Non-Cash Pension Expense	-6.69M	-	-	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	3.63M	-	-	-	-
Net Rental Expense, Total	132M	-	-	158M	136M
Imputed Operating Lease Interest Expense	79.91M	-	-	121M	94.13M
Imputed Operating Lease Depreciation	51.75M	-	-	36.49M	41.63M
Stock-Based Comp., Other (Total)	86.89M	16.99M	-	-7.15M	9.11M
Total Stock-Based Compensation	86.89M	16.99M	-	-7.15M	9.11M

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	2.31B	2.09B	1.71B	3.17B	2.57B
Short Term Investments	92.96M	-	-	179M	157M
Total Cash And Short Term Investments	2.4B	2.09B	1.71B	3.35B	2.72B
Accounts Receivable, Total	1.21B	1.88B	2.16B	1.26B	1.33B
Other Receivables	503M	83.54M	33.4M	669M	506M
Total Receivables	1.71B	1.97B	2.19B	1.92B	1.84B
Inventory	900M	1.02B	871M	956M	852M
Prepaid Expenses	228M	-	-	266M	252M
Other Current Assets, Total	1.13B	1.12B	1.62B	1.52B	5.04B
Total Current Assets	6.36B	6.2B	6.4B	8.02B	10.7B
Gross Property Plant And Equipment	24.51B	-	-	25.74B	26.32B
Accumulated Depreciation	-8.14B	-	-	-9.08B	-9.34B
Net Property Plant And Equipment	16.37B	16.62B	16.75B	16.66B	16.98B
Long-term Investments	5.55B	6.47B	7.93B	7.8B	8.62B
Goodwill	3.87B	3.82B	3.82B	5.74B	5.64B
Other Intangibles, Total	9.58B	11.89B	9.16B	20.19B	19.23B
Accounts Receivable Long-Term	9.74M	-	-	4.59M	4.08M
Loans Receivable Long-Term	70.23M	-	-	30.82M	-
Deferred Tax Assets Long-Term	334M	261M	235M	225M	198M
Deferred Charges Long-Term	-	-	-	30.65M	30.69M
Other Long-Term Assets, Total	5.08B	6.6B	6.92B	5.58B	2.78B
Total Assets	47.22B	51.86B	51.22B	64.27B	64.18B
Liabilities
Accounts Payable, Total	1.16B	2.49B	2.67B	1.29B	1.11B
Accrued Expenses, Total	462M	-	-	1.03B	1.06B
Short-term Borrowings	273M	148M	107M	94.08M	152M
Current Portion of Long-Term Debt	3.59B	804M	2.43B	2.39B	2.82B
Current Portion of Leases	67.13M	-	-	78.87M	89.12M
Current Income Taxes Payable	44.04M	47.93M	32.98M	29.35M	44.82M
Unearned Revenue Current, Total	55.6M	-	-	78.37M	77.57M
Other Current Liabilities	1.22B	418M	402M	670M	926M
Total Current Liabilities	6.87B	3.91B	5.64B	5.66B	6.28B
Long-Term Debt	12.06B	13.68B	11.93B	11.28B	10.02B
Long-Term Leases	399M	381M	429M	264M	229M
Unearned Revenue Non Current	81.03M	-	-	99.59M	95.57M
Pension & Other Post Retirement Benefits	142M	-	-	136M	157M
Deferred Tax Liability Non Current	4.69B	5.38B	4.71B	7.97B	7.75B
Other Non Current Liabilities	160M	347M	326M	97.25M	104M
Total Liabilities	24.39B	23.7B	23.03B	25.5B	24.63B
Common Stock, Total	21.4M	18.17B	19.01B	21.52M	21.06M
Retained Earnings	13.93B	-	-	24.33B	25.87B
Treasury Stock	-1.19M	-	-	-1.39M	-2.23M
Comprehensive Income and Other	370M	-	-	73.15M	-573M
Total Common Equity	14.32B	18.17B	19.01B	24.42B	25.31B
Minority Interest	8.51B	10B	9.19B	14.35B	14.24B
Total Equity	22.83B	28.16B	28.19B	38.77B	39.55B
Total Liabilities And Equity	47.22B	51.86B	51.22B	64.27B	64.18B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	80.87M	80.87M	80.87M	80.55M	75.34M
ECS Total Common Shares Outstanding	80.87M	80.87M	80.87M	80.55M	75.34M
Book Value / Share	177.08	224.66	235.04	303.17	335.97
Tangible Book Value	875M	2.46B	6.02B	-1.5B	450M
Tangible Book Value Per Share	10.82	30.38	74.46	-18.67	5.97
Total Debt	16.38B	15.02B	14.89B	14.1B	13.31B
Net Debt	13.98B	12.92B	13.18B	10.75B	10.58B
Debt Equivalent Oper. Leases	1.05B	-	-	1.26B	1.09B
Minority Interest, Total (Incl. Fin. Div)	8.51B	10B	9.19B	14.35B	14.24B
Equity Method Investments, Total	4.46B	6.47B	7.93B	5.71B	6.93B
Account Code - Inventory Valuation	5	3	3	3	3
Inventories - Raw Materials, Total	399M	-	-	350M	307M
Inventories - Work In Process, Total	71.47M	-	-	49.7M	34.88M
Inventories - Finished Goods, Total	406M	-	-	548M	497M
Inventories - Others	24.62M	-	-	13.05M	16.42M
Film Contract & Broadcasting Rights - Long-Term, Total	330M	-	-	419M	409M
Land - (BS)	13.7B	-	-	13.91B	14.11B
Machinery, Total	9.27B	-	-	10.08B	10.57B
Accumulated Allowance for Doubtful Accounts (Supple)	46.9M	-	-	80.89M	85.06M

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	2.08B	3.21B	652M	6.72B	2.54B
Depreciation & Amortization - CF	1.17B	1.16B	1.22B	1.11B	1.12B
Amortization of Goodwill and Intangible Assets - (CF)	11.21M	-	-	36.92M	38.06M
Depreciation & Amortization, Total	1.18B	1.16B	1.22B	1.15B	1.15B
Amortization of Deferred Charges, Total - (CF)	-	-	-	15.13M	18.98M
(Gain) Loss From Sale Of Asset	-17.86M	-	-	-10.22M	46.1M
(Gain) Loss on Sale of Investments - (CF)	-181M	-	-	-5.19B	-815M
Asset Writedown & Restructuring Costs	-1.14B	-	-	1.53B	70.11M
(Income) Loss On Equity Investments - (CF)	93.6M	-	-	-77.44M	-524M
Stock-Based Compensation (CF)	23.46M	-	-	-7.15M	9.11M
Provision and Write-off of Bad Debts	-2.58M	-	-	33.81M	46.89M
Net Cash From Discontinued Operations	5.04M	-	-	-	-
Other Operating Activities, Total	493M	-380M	2B	-1.02B	900M
Change In Accounts Receivable	-95.89M	-	-	-22.81M	147M
Change In Inventories	-	-	-	-121M	108M
Change In Accounts Payable	124M	-	-	-281M	-166M
Change in Other Net Operating Assets	95.98M	-491M	-365M	-14.02M	68.29M
Cash from Operations	2.66B	3.5B	3.5B	2.7B	3.6B
Capital Expenditure	-537M	-1.08B	-1.15B	-1.09B	-1.19B
Sale of Property, Plant, and Equipment	168M	181M	44.89M	75.5M	21.02M
Cash Acquisitions	-	-276M	-	-	-44.74M
Divestitures	107M	-	-	328M	-
Sale (Purchase) of Real Estate properties	-134M	-83.57M	-18.05M	-27.23M	63.73M
Sale (Purchase) of Intangible assets	-4.9M	-191M	-109M	1.66B	-118M
Investment in Marketable and Equity Securities, Total	-123M	-618M	-1.57B	-6.38M	111M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	87.88M	23.31M	39K	5.85M
Other Investing Activities, Total	104M	133M	95.48M	195M	229M
Cash from Investing	-420M	-1.84B	-2.68B	1.13B	-922M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	467M	-	-	2.33B	2.24B
Total Debt Issued	467M	-	-	2.33B	2.24B
Long-Term Debt Repaid, Total	-1.92B	-1.22B	-352M	-3.39B	-3.47B
Total Debt Repaid	-1.92B	-1.22B	-352M	-3.39B	-3.47B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-	-	-	-38.5M	-802M
Common Dividends Paid	-	-499M	-700M	-1.34B	-549M
Common & Preferred Stock Dividends Paid	-	-499M	-700M	-1.34B	-549M
Other Financing Activities, Total	-87.57M	-34.7M	-109M	9M	-539M
Cash from Financing	-1.54B	-1.75B	-1.16B	-2.43B	-3.12B
Foreign Exchange Rate Adjustments	-453K	1.06M	1.09M	64.61M	-99.42M
Net Change in Cash	695M	-92.63M	-339M	1.47B	-536M
Supplemental Items
Cash Interest Paid	1.7B	-	-	1.21B	977M
Cash Income Tax Paid (Refund)	619M	892M	976M	924M	1B
Levered Free Cash Flow	2.27B	1.87B	1.65B	3.41B	-1.38B
Unlevered Free Cash Flow	3.1B	2.61B	2.54B	4.29B	-634M
Change In Net Working Capital	32.57M	98.24M	438M	5.1M	3.19B
Net Debt Issued / Repaid	-1.45B	-1.22B	-352M	-1.06B	-1.23B

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	5.17	5.65	5.86	4.45	4.17
Return on Total Capital	6.24	6.81	7	5.35	5.07
Return On Equity %	15.17	19.96	2.65	20.97	8.91
Return on Common Equity	15.83	19.8	3.51	30.97	10.21
Margin Analysis
Gross Profit Margin %	100	24.63	25.48	22.36	22.46
EBITDA Margin %	26.31	24.63	25.48	22.03	22.13
EBITA Margin %	20.21	19.55	20.34	17.69	17.89
EBIT Margin %	20.15	19.55	20.34	17.53	17.73
Income From Continuing Operations Margin %	16.79	22.22	3.14	29.96	14.43
Net Income Margin %	10.87	14.01	2.75	28.69	10.5
Net Avail. For Common Margin %	10.91	14.04	2.75	28.69	10.5
Normalized Net Income Margin	2.61	1.95	8.64	6.86	6.04
Levered Free Cash Flow Margin	11.89	8.14	6.94	14.56	-5.69
Unlevered Free Cash Flow Margin	16.21	11.41	10.69	18.29	-2.62
Asset Turnover
Asset Turnover	0.41	0.46	0.46	0.41	0.38
Fixed Assets Turnover	1.15	1.39	1.42	1.4	1.44
Receivables Turnover (Average Receivables)	17.47	12.29	11.74	17.88	18.7
Inventory Turnover (Average Inventory)	-	17.97	18.7	19.91	20.74
Short Term Liquidity
Current Ratio	0.93	1.58	1.13	1.42	1.7
Quick Ratio	0.6	1.04	0.69	0.93	0.73
Operating Cash Flow to Current Liabilities	0.39	0.89	0.62	0.48	0.57
Days Sales Outstanding (Average Receivables)	20.89	29.69	31.16	20.42	19.52
Days Outstanding Inventory (Average Inventory)	-	20.31	19.58	18.33	17.6
Average Days Payable Outstanding	-	54.64	53.87	25.35	23.5
Cash Conversion Cycle (Average Days)	-	-4.64	-3.13	13.39	13.62
Long Term Solvency
Total Debt/Equity	71.77	53.31	52.82	36.38	33.64
Total Debt / Total Capital	41.78	34.77	34.56	26.68	25.17
LT Debt/Equity	54.56	49.93	43.82	29.77	25.9
Long-Term Debt / Total Capital	31.77	32.57	28.68	21.83	19.38
Total Liabilities / Total Assets	51.66	45.69	44.96	39.68	38.38
EBIT / Interest Expense	2.91	3.75	3.39	2.94	3.61
EBITDA / Interest Expense	3.81	4.72	4.24	3.76	4.58
(EBITDA - Capex) / Interest Expense	3.4	3.82	3.44	2.98	3.58
Total Debt / EBITDA	3.25	2.66	2.46	2.68	2.45
Net Debt / EBITDA	2.78	2.29	2.18	2.05	1.95
Total Debt / (EBITDA - Capex)	3.64	3.29	3.04	3.39	3.13
Net Debt / (EBITDA - Capex)	3.11	2.83	2.69	2.58	2.49
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	35.8	20.14	3.64	-1.25	3.14
Gross Profit, 1 Yr. Growth %	35.8	12.54	7.23	-13.32	3.58
EBITDA, 1 Yr. Growth %	61.95	12.54	7.23	-13.05	3.59
EBITA, 1 Yr. Growth %	104.57	16.46	7.84	-14.5	4.32
EBIT, 1 Yr. Growth %	105.49	16.46	7.84	-14.92	4.33
Earnings From Cont. Operations, 1 Yr. Growth %	188.22	58.83	-85.34	841.7	-50.34
Net Income, 1 Yr. Growth %	-303.17	54.29	-79.67	931.46	-62.25
Normalized Net Income, 1 Yr. Growth %	-79.26	-9.35	358.89	-21.53	-9.31
Diluted EPS Before Extra, 1 Yr. Growth %	94.31	51.93	-79.79	935.32	-60.9
Accounts Receivable, 1 Yr. Growth %	22.39	2.26	14.55	-8.11	5.95
Inventory, 1 Yr. Growth %	44.89	13.49	-14.69	9.8	-10.96
Net Property, Plant and Equip., 1 Yr. Growth %	-3.49	1.55	0.75	-0.5	1.91
Total Assets, 1 Yr. Growth %	2.76	9.83	-1.24	25.48	-0.14
Tangible Book Value, 1 Yr. Growth %	-188.65	180.72	145.11	-124.89	-129.9
Common Equity, 1 Yr. Growth %	18.71	26.87	4.62	28.47	3.66
Cash From Operations, 1 Yr. Growth %	87.99	28.07	0.11	-22.93	33.45
Capital Expenditures, 1 Yr. Growth %	0.02	100.25	6.96	-5.08	8.87
Levered Free Cash Flow, 1 Yr. Growth %	100.78	-12.92	-10.86	94.82	-140.3
Unlevered Free Cash Flow, 1 Yr. Growth %	48.78	-12.01	-2.18	62.35	-114.78
Dividend Per Share, 1 Yr. Growth %	-	-	100	70	17.65
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-4.91	27.5	11.59	1.17	0.92
Gross Profit, 2 Yr. CAGR %	84.99	-36.73	9.85	-3.59	-5.25
EBITDA, 2 Yr. CAGR %	-7.32	34.7	9.85	-4.31	-5.09
EBITA, 2 Yr. CAGR %	-5.59	53.93	12.07	-3.78	-5.56
EBIT, 2 Yr. CAGR %	-5.73	54.5	12.07	-4.21	-5.79
Earnings From Cont. Operations, 2 Yr. CAGR %	-20.03	113.68	-51.75	17.48	116.25
Net Income, 2 Yr. CAGR %	-26.09	77.05	-44	44.8	97.33
Normalized Net Income, 2 Yr. CAGR %	-69.11	-56.92	103.96	89.77	-15.64
Diluted EPS Before Extra, 2 Yr. CAGR %	19.31	71.5	-44.58	44.66	101.21
Accounts Receivable, 2 Yr. CAGR %	-29.75	38.32	8.23	-18.36	-1.33
Inventory, 2 Yr. CAGR %	-7.63	28.23	-1.61	-3.22	-1.12
Net Property, Plant and Equip., 2 Yr. CAGR %	-21.93	-1	1.15	0.12	0.7
Total Assets, 2 Yr. CAGR %	-14.7	6.24	4.15	11.32	11.94
Tangible Book Value, 2 Yr. CAGR %	-7.37	57.75	162.31	-21.75	-72.72
Common Equity, 2 Yr. CAGR %	7.69	22.72	15.21	15.94	15.4
Cash From Operations, 2 Yr. CAGR %	-14.78	57.37	13.23	-12.16	1.41
Capital Expenditures, 2 Yr. CAGR %	-44.77	41.53	46.35	0.76	1.66
Levered Free Cash Flow, 2 Yr. CAGR %	58.45	28.33	-12.3	35.9	-11.39
Unlevered Free Cash Flow, 2 Yr. CAGR %	21.5	11.96	-7.53	28.51	-51.01
Dividend Per Share, 2 Yr. CAGR %	-	-	-	84.39	41.42
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-8.69	2.67	18.99	7.13	1.82
Gross Profit, 3 Yr. CAGR %	42.66	0.29	-24.56	1.51	-1.26
EBITDA, 3 Yr. CAGR %	-8.58	-1.28	24.84	1	-1.75
EBITA, 3 Yr. CAGR %	-9.07	1.07	36.71	2.54	-1.16
EBIT, 3 Yr. CAGR %	-9.16	1.07	37.05	2.23	-1.45
Earnings From Cont. Operations, 3 Yr. CAGR %	21.55	0.44	-12.53	29.9	-11.83
Net Income, 3 Yr. CAGR %	43.19	-5.54	-13.95	47.9	-7.5
Normalized Net Income, 3 Yr. CAGR %	-23.95	-55.97	-5.21	48.34	48.37
Diluted EPS Before Extra, 3 Yr. CAGR %	40.96	29.16	-15.91	47.05	-6.46
Accounts Receivable, 3 Yr. CAGR %	-20.37	-8.28	29.89	-11.99	-10.95
Inventory, 3 Yr. CAGR %	-3.31	-1.07	11.94	2.06	-5.87
Net Property, Plant and Equip., 3 Yr. CAGR %	-13.95	-14.78	-0.42	0.59	0.71
Total Assets, 3 Yr. CAGR %	-13.35	-7.2	3.68	10.82	7.36
Tangible Book Value, 3 Yr. CAGR %	-50.67	34.04	82.71	19.79	-43.22
Common Equity, 3 Yr. CAGR %	-3.95	13.74	16.36	19.47	11.69
Cash From Operations, 3 Yr. CAGR %	-12.44	-1.46	35.35	-0.4	0.98
Capital Expenditures, 3 Yr. CAGR %	-37.5	-15.15	28.91	26.68	3.4
Levered Free Cash Flow, 3 Yr. CAGR %	20.86	27.23	13.31	16.8	-9.37
Unlevered Free Cash Flow, 3 Yr. CAGR %	7.81	7.54	6.8	13.02	-37.5
Dividend Per Share, 3 Yr. CAGR %	-	-3.13	-	-	58.74
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-3.71	-0.83	-1.13	2.07	11.4
Gross Profit, 5 Yr. CAGR %	-3.71	-25.07	-1.7	-1.28	-17.36
EBITDA, 5 Yr. CAGR %	-5.09	-2.29	-1.7	-2.5	11.47
EBITA, 5 Yr. CAGR %	-5.6	-1.92	-1.25	-0.9	18
EBIT, 5 Yr. CAGR %	-5.66	-1.92	-1.25	-1.08	17.97
Earnings From Cont. Operations, 5 Yr. CAGR %	-2.95	19.36	-16.05	6.94	25.63
Net Income, 5 Yr. CAGR %	10.92	27.83	-1.64	12.06	19.93
Normalized Net Income, 5 Yr. CAGR %	10.53	-17.3	12.55	-21.01	-9.53
Diluted EPS Before Extra, 5 Yr. CAGR %	10.36	32.38	-3.04	35.15	19.2
Accounts Receivable, 5 Yr. CAGR %	-4.45	6.72	-1.99	-12.46	6.2
Inventory, 5 Yr. CAGR %	-1.2	1.67	-2.63	-1.93	6.52
Net Property, Plant and Equip., 5 Yr. CAGR %	-8.21	-7.77	-8.2	-9.1	0.02
Total Assets, 5 Yr. CAGR %	-7.71	-5.91	-6.74	-0.19	6.91
Tangible Book Value, 5 Yr. CAGR %	-36.73	-21.28	-3.76	8.08	-14.55
Common Equity, 5 Yr. CAGR %	-1.89	3.53	3.3	14.61	15.98
Cash From Operations, 5 Yr. CAGR %	-9.37	-2.61	-2.4	-5.89	20.59
Capital Expenditures, 5 Yr. CAGR %	-21.94	-8.53	-12.16	-9.11	17.23
Levered Free Cash Flow, 5 Yr. CAGR %	-2.5	3.37	5.05	30.39	3.97
Unlevered Free Cash Flow, 5 Yr. CAGR %	-2.86	-0.73	0.51	15.34	-21.19
Dividend Per Share, 5 Yr. CAGR %	-	-26.93	-17.71	25.32	-